TickerTalks
Browse all tickers →
TickerTalks›$LFVN
LFLFVN

LifeVantage Corporation

Trending onTrending downwardX mentions rising faster than the marketRecent insider buyingBullish-leaning chatter
$LFVN·$79M·Packaged Foods·Consumer Defensive
$6.20+0.0%YTD-0.8%1Y-49.9%
Mentions · last 7 days
2026-07-07: 0 posts2026-07-08: 1 posts2026-07-09: 1 posts2026-07-10: 0 posts2026-07-11: 1 posts2026-07-12: 1 posts2026-07-13: 6 posts100%
Price updated 13m ago·X counts updated 2d ago
LFLFVN
$LFVNLifeVantage Corporation
$6.20+0.00%10 posts0%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $LFVN, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Broken storyWinding up for a moveAI verdict · as of 2026-07-15

Trading in a tight range and building pressure — a move looks likely soon, but the direction isn't clear yet.

LifeVantage revenue down 25%+ across the trailing year — the crowd is pricing a short squeeze that fundamentals do not support.

LifeVantage is a small-cap wellness / MLM name where the trend is unambiguously negative and a bull thesis is being manufactured on technical / squeeze grounds.

  • Revenue collapse: Q3 FY2026 (Mar) $43.7M (-25.2% YoY), Q2 FY2026 $48.9M (-27.8% YoY), Q1 FY2026 $47.6M (+0.7%), Q4 FY2025 $55.1M (+12.6%) — the last two quarters have snapped down materially.
  • Miss cadence: -25%, -21%, +6%, 0% across last four quarters — analysts had expected a stabler trajectory and the recent quarters have disappointed.
  • Margin discipline holds: Gross margin 78-80%, operating margin 3.4-4.8% — the business is cash-flow-positive at this reduced revenue level, which is why PE remains a positive 21.9x and FCF yield 3.0%.
  • Insider signal is mixed but interesting: Jun 15 director Darwin Lewis P-Purchase of 705 shares at $8.60 ($6,060) — small but a discretionary open-market buy from a director at a price above current $6.20; a signal, not confirmation.
  • Setup: $6.20, roughly flat YTD, -50% over 12 months, sitting at 21% of 52-week range and slightly below both moving averages; float not on file (coverage flag).

Sep 3 fiscal Q4 2026 print is where the top-line has to at least stabilize; a fifth soft print would tell you the wellness / MLM channel-recruitment issue is structural.

Differs from X sentimentX sentiment frames LFVN as an active short-squeeze setup with tight borrow, elevated CTB, and daily borrow costs cited around $244K. The setup is technically plausible, but the underlying revenue collapse and 50% 12-month drawdown argue the short thesis is grounded in real deterioration — squeeze mechanics can move the tape short-term without changing the fundamental read.

What to watch: Sep 3 fiscal Q4 print — revenue stabilization, active-consultant count trend, new-consultant enrollment; continued Darwin Lewis (or other director) open-market buying pattern; short-interest data as squeeze-thesis validation or invalidation.

On the calendar: 2026-09-03 — Q4 FY2026 earnings (EPS est $0.15)

small capfloat missingmlm business modelrevenue declining

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Bullish sentiment5 posts analyzed · as of 2026-06-15

LifeVantage is being framed as an active short-squeeze setup, with shorts having not covered, a tight borrow market, an elevated CTB, and daily borrow costs around $244K per day for shorts. Bulls flag the $10 level as critical to reclaim. Sentiment is bullish on the squeeze dynamics.

Read the AI verdict + X sentiment for $LFVN

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Sells Protandim NRF2 antioxidant supplements and skincare products via direct sales network; multi-level marketing wellness brand.

Industry overviewAI analysisGenerated by AI from underlying data

Where Packaged Foods sits in its cycle right now — and what that implies for $LFVN.

Packaged Foods · Consumer Defensive

No material change from last week — WEST's private-label coffee co-packing benefits from consumer switching from branded to value coffee, while DAR's food waste conversion to bio-based..

What this means for $LFVN

Partial — Sells Protandim NRF2 antioxidant supplements and skincare products via direct sales network; multi-level marketing wellness brand; exposure exists but is diluted by diverse end markets and revenue mix.

Industry benchmark

11-name peer basket
+18.3%YTD
+7.1%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
21.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
12.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
3.4%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
3.0%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.6Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
17.8%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
78.1%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.3Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026May 6, 2026$0.12$0.16-25.0%
Q4 2025Feb 4, 2026$0.15$0.19-21.1%
Q3 2025Nov 4, 2025$0.18$0.17+5.9%
Q2 2025Sep 4, 2025$0.17$0.170.0%
Next earningsThu, Sep 3·consensus EPS $0.15

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q3 FY26$43.7M-25.2%79.0%3.8%$0.11$4.0M
Q2 FY26$48.9M-27.8%74.0%1.0%$0.02$1.7M
Q1 FY26$47.6M+0.7%79.5%4.8%$0.17$-2.7M
Q4 FY25$55.1M+12.6%79.9%3.9%$0.16$835K

Forward consensus

4-year forecast · up to 2 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$184.2M$178.2M – $188.1M$0.57$0.55 – $0.592
FY27$178.4M$172.5M – $182.1M$0.46$0.44 – $0.472
FY28$165.3M$159.9M – $168.8M$0.41$0.39 – $0.421
FY29$291.6M$282.0M – $297.7M$1.55$1.48 – $1.591

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.2×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.21%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-7.4%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-1.9%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

β0.765-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyJun 15Darwin LewisDirector705 sh$6KSellJun 3Michael A BeindorffDirector10.0K sh$85KBuyMar 16Darwin LewisDirector1.1K sh$6KBuyMar 2Judd DaytonDirector10.5K sh$48KBuyFeb 27Judd DaytonDirector18.1K sh$84KBuyFeb 26Judd DaytonDirector4.6K sh$21KBuyFeb 9Darwin LewisDirector4.0K sh$21K
+ 7 other (7 inkinds) in window

See when $LFVN insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KOfficer or director changeApr 168-K — Item 5.02: Officer or director change
AI summary

LifeVantage Corporation announced that CEO Steven R. Fife will retire effective April 30, 2026, with new CEO Terrence O. Moorehead (age 63) taking over on August 5, 2026 per a transition agreement dated April 15, 2026. Moorehead was previously CEO of Nature's Sunshine Products (2018-2025) and has 25+ years in the direct selling and retail consumer products industries. The gap between Fife's April 30 departure and Moorehead's August 5 start implies an interim leadership period.

S-3Shelf registrationMar 10S-3
8-KOfficer or director changeFeb 48-K — Item 2.02: Earnings release · Item 5.02: Officer or director change
+ 8 other (2 13Gs · 2 10-Qs · 1 earnings 8-K · 1 EFFECT) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Do Options Traders Know Something About LifeVantage Stock We Don't?zacks.com·49d agoLifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcriptseekingalpha.com·70d agoLifevantage (LFVN) Q3 Earnings and Revenues Miss Estimateszacks.com·70d agoLifeVantage Declares Quarterly Dividendglobenewswire.com·70d agoLifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026globenewswire.com·70d ago

In themes

Explore the broader themes this ticker is being talked about under.

Trending on X

More in Packaged Foods

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$KHC$CPB$GIS$MKC$DAR$SJM$SMPL$MAMA
Voices on X · last 7 days

No standout posts about $LFVN on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport